Literature DB >> 1719958

Effects of human recombinant interleukin-1 beta on protein synthesis in rat tissues compared with a classical acute-phase reaction induced by turpentine. Rapid response of muscle to interleukin-1 beta.

P E Ballmer1, M A McNurlan, B G Southorn, I Grant, P J Garlick.   

Abstract

The early time course (1, 3, 9, 24 h) of changes in rates of protein synthesis (ks) in liver and three different muscles (gastrocnemius, soleus and heart) was investigated after injection of saline, interleukin-1 beta (IL-1) or turpentine in rats. IL-1 injection induced a consistent increase in body temperature of about 3 degrees C between 3 and 5 h, but thereafter a hypothermic response occurred. With turpentine, a delayed fever response with a peak value by 9 h was observed. Both IL-1 and turpentine had no effect on protein synthesis in the small intestine, but produced a significant increase in ks in the liver at 9 h. By 24 h in IL-1-treated animals, liver ks had returned back to control values, whereas the turpentine-treated group showed a progressive rise in ks. Gastrocnemius and soleus muscles exhibited a significant fall in ks at 9 h after IL-1 and turpentine injection compared with the control. In contrast, the ks of heart muscle increased at 3-9 h after IL-1 injection, but there was no effect of turpentine. Thus for the first time a marked decrease of protein synthesis in skeletal muscle in response to IL-1 could be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719958      PMCID: PMC1151499          DOI: 10.1042/bj2790683

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Effect of malaria on rate of protein synthesis in individual tissues of rats.

Authors:  E B Fern; M A McNurlan; P J Garlick
Journal:  Am J Physiol       Date:  1985-11

2.  Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.

Authors:  T Gulick; M K Chung; S J Pieper; L G Lange; G F Schreiner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  In vivo rates of protein synthesis in brain, muscle, and liver of five vertebrate species.

Authors:  J F Sayegh; A Lajtha
Journal:  Neurochem Res       Date:  1989-11       Impact factor: 3.996

4.  Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.

Authors:  Y Fong; L L Moldawer; M Marano; H Wei; A Barber; K Manogue; K J Tracey; G Kuo; D A Fischman; A Cerami
Journal:  Am J Physiol       Date:  1989-03

5.  Comparative effects of tumour necrosis factor-alpha (cachectin), interleukin-1-beta and tumour growth on amino acid metabolism in the rat in vivo. Absorption and tissue uptake of alpha-amino[1-14C]isobutyrate.

Authors:  J M Argilés; F J López-Soriano; D Wiggins; D H Williamson
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

6.  Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1.

Authors:  E A Flores; B R Bistrian; J J Pomposelli; C A Dinarello; G L Blackburn; N W Istfan
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

7.  Effect of recombinant human tumour necrosis factor alpha on protein synthesis in liver, skeletal muscle and skin of rats.

Authors:  Y Charters; R F Grimble
Journal:  Biochem J       Date:  1989-03-01       Impact factor: 3.857

Review 8.  Interleukin-1 and the pathogenesis of the acute-phase response.

Authors:  C A Dinarello
Journal:  N Engl J Med       Date:  1984-11-29       Impact factor: 91.245

9.  Human recombinant interleukin-1 beta decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats.

Authors:  J M Dubuis; J M Dayer; C A Siegrist-Kaiser; A G Burger
Journal:  Endocrinology       Date:  1988-11       Impact factor: 4.736

10.  Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines.

Authors:  L L Moldawer; C Andersson; J Gelin; K G Lundholm
Journal:  Am J Physiol       Date:  1988-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.